Thu, Dec 25, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Winton Capital's Bill Miller joins Drury Capital

Tuesday, May 08, 2012
Opalesque Industry Update - Bill Miller, former Head of European Sales for leading hedge fund Winton Capital has joined Princeton based CTA Drury Capital as Head of Global Sales with responsibility to push further the Drury Capital brand in North America, Europe and the Far East.

Drury Capital was founded in 1997, by Bernard Drury and is a systematic longer term trend following manager CTA, with particular emphasis on commodity trading. Miller is a well-known and highly respected figure on the CTA/managed futures stage and has a strong track record in this highly specialised sector.

Drury Capital has seen strong performance in the first quarter of 2012 enjoying an increase of 8%. Miller said: “ Although we have had strong growth of 8% in the first quarter, and I do anticipate there will still be volatile markets, I believe our strong diversification within the futures markets and specific emphasis on commodities, as well as our longer style of trading, will provide performance that will set us apart from the rest of the market and deliver tangible results for our investors.” Miller will be also responsible for setting up the Drury Capital London office, subject to FSA authorisation.

Press release

bc

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its